This signaling pathway, however, is inhibited following pressure-overload hypertrophy, likely mediated by enhanced signaling of CaMKII and p53, providing an explanation for the functional decompensation and adverse ventricular remodeling in β2-TG hearts after TAC. This evidence concerns the gene CAMK2G and persistent truncus arteriosus.